BR9808470A - Mistura de ácidos graxos primários de alto peso molecular obtidos a partir de cera da cana-de-açúcar e seus usos farmacêuticos - Google Patents

Mistura de ácidos graxos primários de alto peso molecular obtidos a partir de cera da cana-de-açúcar e seus usos farmacêuticos

Info

Publication number
BR9808470A
BR9808470A BR9808470-4A BR9808470A BR9808470A BR 9808470 A BR9808470 A BR 9808470A BR 9808470 A BR9808470 A BR 9808470A BR 9808470 A BR9808470 A BR 9808470A
Authority
BR
Brazil
Prior art keywords
mixture
fatty acids
molecular weight
high molecular
sugar cane
Prior art date
Application number
BR9808470-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Luis Gonzales Bravo
David Marrero Delange
Abilio Laguna Granja
Rosa Maria Mas Ferreiro
Maria De Lourdes Arruz Valmana
Daysi Carbajal Quintana
Mirian Cora Medina
Roberto Menendez Soto De Valle
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Publication of BR9808470A publication Critical patent/BR9808470A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9808470-4A 1997-04-02 1998-04-01 Mistura de ácidos graxos primários de alto peso molecular obtidos a partir de cera da cana-de-açúcar e seus usos farmacêuticos BR9808470A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
PCT/IB1998/000870 WO1998043631A1 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax

Publications (1)

Publication Number Publication Date
BR9808470A true BR9808470A (pt) 2000-05-23

Family

ID=5459247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808470-4A BR9808470A (pt) 1997-04-02 1998-04-01 Mistura de ácidos graxos primários de alto peso molecular obtidos a partir de cera da cana-de-açúcar e seus usos farmacêuticos

Country Status (19)

Country Link
US (1) US6486205B2 (OSRAM)
EP (1) EP0969827B1 (OSRAM)
JP (2) JP4907750B2 (OSRAM)
CN (1) CN1230158C (OSRAM)
AR (1) AR016054A1 (OSRAM)
AT (1) ATE233087T1 (OSRAM)
AU (1) AU732045B2 (OSRAM)
BR (1) BR9808470A (OSRAM)
CA (1) CA2285242C (OSRAM)
CO (1) CO4940484A1 (OSRAM)
CU (1) CU22723A1 (OSRAM)
DE (1) DE69811643T2 (OSRAM)
DK (1) DK0969827T3 (OSRAM)
ES (1) ES2192769T3 (OSRAM)
MY (1) MY120318A (OSRAM)
PT (1) PT969827E (OSRAM)
RU (1) RU2217130C2 (OSRAM)
WO (1) WO1998043631A1 (OSRAM)
ZA (1) ZA982744B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
US7649103B2 (en) * 2002-06-17 2010-01-19 Medestea Research And Production S.R.L. Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第1級脂肪族高級アルコ−ルの抽出法
DE69026496D1 (de) * 1989-10-13 1996-05-15 Neurofit Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
CN1230158C (zh) 2005-12-07
RU2217130C2 (ru) 2003-11-27
JP2001518092A (ja) 2001-10-09
CA2285242C (en) 2008-12-16
MY120318A (en) 2005-10-31
JP4907750B2 (ja) 2012-04-04
DK0969827T3 (da) 2003-06-16
ES2192769T3 (es) 2003-10-16
DE69811643D1 (de) 2003-04-03
AR016054A1 (es) 2001-06-20
CA2285242A1 (en) 1998-10-08
CN1258218A (zh) 2000-06-28
AU7349498A (en) 1998-10-22
WO1998043631A1 (en) 1998-10-08
JP2012067119A (ja) 2012-04-05
DE69811643T2 (de) 2003-12-24
EP0969827A1 (en) 2000-01-12
ZA982744B (en) 1998-10-08
US20020058705A1 (en) 2002-05-16
CO4940484A1 (es) 2000-07-24
ATE233087T1 (de) 2003-03-15
PT969827E (pt) 2003-07-31
US6486205B2 (en) 2002-11-26
HK1029054A1 (en) 2001-03-23
EP0969827B1 (en) 2003-02-26
AU732045B2 (en) 2001-04-12
CU22723A1 (es) 2002-02-28

Similar Documents

Publication Publication Date Title
ES2192769T3 (es) Mezcla de acidos grasos primarios obtenidos de cera de caña de azucar.
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
BR9713699A (pt) Preparado cosmético com um aditivo de peptìdio e utilização do mesmo
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
BR9815159A (pt) Preparação de conjugados de polietileno glicol-grf especìfica ao sìtio
TR200201509T2 (tr) Farmasötik olarak aktif benzazol türevleri.
CZ76995A3 (en) Derivatives of 1-(oxoacetyl)pipridine-2-carboxylic acid, process of their preparation pharmaceutical composition containing thereof and their use
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
BR0008059A (pt) Composições de valdecoxib
GT199900146A (es) Derivados de 4,4-biarilpiperidina.
BRPI9917007B8 (pt) azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso
ATE205494T1 (de) Pyridylfuran- und pyridylthiphenderivate und deren pharmazeutische verwendung
BR9812944A (pt) Inibidores bicìclicos da cinase
BR9812001A (pt) Composição farmacêutica para combinação de descongestionante piperidinoalcanol
NO161262C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive s- adenosyl-l-metionin (sam) salter.
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
BR9810729A (pt) Composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsionante
AR029190A1 (es) Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco
ES2089497T3 (es) Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
KR900005964A (ko) 분산성 제형
CU22412A1 (es) Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
BR9814284A (pt) Composições e métodos para regulação de fagocitose e expressão de icam-1
BR0114082A (pt) Compostos, composições farmacêuticas, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
BR9914441A (pt) Composição de alta pureza compreendendo (7-alfa, 17-alfa) - 17-hidroxi-7-metil-19-nor-17-pregn- 5(10)-en-20-in-3-ona, processo para preparar as composições de alta pureza, e, unidade de dosagem farmacêutica

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/20 (2006.01)